SponsorsBack to top
We thank the following companies for their generous support of the Artificial Vision Symposium 2017 in Aachen:
|
|
|
AACHEN, AND THE EUREGIO AREABack to top
The city of Aachen is the most western city in Germany close to the borders of The Netherlands and Belgium. Aachen has approx. 250,000 inhabitants and the University and the University Hospital are the largest workgiver here in Aachen. Aachen has a long history and you can still see significant witnesses of a time long ago, such as the cathedral with its beautiful and mystic octagon and the astonishing gothic city hall. But Aachen with its important historic phase of Charlemagne today is a young and vivid town with its university and the many students from various countries in the world. RWTH Aachen University is one of the leading technical universities in Europe with a strong focus on mechanical and electrical engineering but also on information technology and natural sciences. Aachen forms a cultural, industrial and also scientific cross border triangle together with Liege in Belgium and Maastricht in The Netherlands forming the EUREGIO area. Many cooperations exist between the institutions within this area.
The Artificial Vision Meeting is set to the beginning of December. Although the weather might not be perfect – in fact it could be cold and maybe rainy – it is worth to visit the cosy Christmas Market in the city. You should try “Printen”, a local biscuit speciality with a high “addiction” potential.
Aachen is also not far away from Cologne with its huge cathedral and its several concert halls and the province capital Düsseldorf with its important art and fashion scene. You can also reach the European capitals Paris and Brussels with a high speed train within a few hours.
There are also many more reasons to come and visit Aachen and we are looking forward to see you.
PrefaceBack to top
Dear Colleagues and Friends,
on behalf of the organizers of the 2017 Artificial Vision Meeting it is my pleasure to welcome you all here in Aachen/Germany. The Aachen Meeting on Artificial Vision was established to provide a platform for researchers to present and to discuss new data. It should also serve as a market place for people to meet, to exchange ideas and to fi nd partners for joint projects.
The meeting covers a broad spectrum of aspects from retinal physiology, technology and microsystems engineering, biophysics and clinical ophthalmology. In this respect the Artificial Vision Projects are best practice examples for interdisciplinary translational research projects.
The development of visual prostheses started early some 60 – 50 years ago in a first phase and was „re-launched“ in a second phase in the mid 90ies. Now we are looking forward to a third phase with emerging new technologies and deeper insights into the pathophysiology of the degenerated visual system. The second phase was extremely exciting because the ideas were transferred to clinical products and today we are able to analyze outcome data of the first and second generation retinal implants. Surely, the results are limited and maybe not within the range we all previously expected. However, there are previously blind patients performing extremely well with these implants. There is still a long and rough road ahead of us to further improve the concepts and the systems. What at least has been shown is that the concept of restoring visual percepts using implantable devices is working and that it is safe. Comparing the technological approach with genetic or cell based approaches it seems more and more evident that the biological approaches need some healthy structures in the retina. In the very advanced and late cases of retinal degeneration where all of the retinal photoreceptors are gone the prosthetic approach seems to be the only possible way.
We all wish that this symposium will be a great meeting for all the participants. We encourage everyone to attend this meeting and to get into contact with other researchers, making new contacts and friends. We are encouraging international networking between the groups and also between the worlds of ”epi-”, ”sub-”, ”supra-”, or cortical, or other approaches. At the end our goal is the same.
We are thankful for the industry for their generous support and also for the DFG for their support of this meeting.
Sincerely,
Peter Walter
RWTH Aachen University
together with Wilfried Mokwa,
Frank Müller, and Andreas Offenhäusser
General InformationBack to top
Date |
Friday, 1st December, 2017, 13:00 h – 18:40 h |
|||||||||
Opening hours congress office |
Friday, 1st December, 2017, 12:00 h – 18:40 h |
|||||||||
Opening hours industrial exhibition |
Friday, 1st December, 2017, 13:00 h – 18:40 h |
|||||||||
Official Language |
English |
|||||||||
Venue |
Center for Technology Europaplatz |
|||||||||
Lecture hall |
Auditorium |
|||||||||
Homepage and Online Registration |
||||||||||
Hotel booking |
See hotel on the registration form |
|||||||||
Scientific programme and further information |
Prof. Dr. Peter Walter |
|||||||||
Organization |
Congress-Organisation Gerling GmbH |
|||||||||
|
Attendance Fee
|
*PhD Students and residents must supply a letter of verification as proof of training. The letter has to be sent to the congress organization prior to the meeting.
The attendance fee covers the costs for coffee breaks, lunch, and the conference dinner (accompanying person EUR 50,–). |
|||||||||
Payment |
by bank transfer (bank details are quoted on your confirmation and invoice. Please do not transfer money without noting your invoice number!) PayPal or by credit card: VISA, AMERICAN EXPRESS, MASTERCARD |
|||||||||
Important notes for participants |
If you register late or on site, we cannot guarantee for lunch and participation at the social program. You are encouraged to apply for the meeting either online, by mail or by fax.
Cancellation for the symposium has to be made via e-mail or via fax (+49 (0) 2 11 / 59 35
60) by 27th November, 2017. In any case an administration fee of EUR 22,– has to be paid. |
Information for speakers
Presentations |
15 min presentation incl. discussion |
Projection |
Microsoft PowerPoint presentation on CD/DVD/USB-Stick or own notebook. |
Social EventBack to top
Friday, 1st December, 2017
20:00 h |
Conference Dinner
Drehturm Belvedere
Price per person (incl. dinner and drinks):
Bus transfer from the congress venue: 19:30 h |
Scientific ProgrammeBack to top
Friday, 1st December, 2017
13:00 h |
Come Together |
14:00 h |
Prof. Dr. med. Peter Walter
Univ.-Prof. Dr. rer. nat. Stefan Uhlig
Dr.-Ing. Damian Dudek
Helma Gusseck |
14:40 h |
1st Session Retinal Degeneration and Retina Stimulation – BasicsChair:Frank Müller (Jülich/D) Daniel Rathbun (Tübingen/D) |
01 |
Daniel Rathbun (University of Tübingen, Institut for Ophthalmic Resource, Tübingen/D) |
02 |
Anna-Marina van der Meer1, F. Müller2, S. Johnen1, P. Walter1 (1Department of
Ophthalmology, RWTH Aachen University, Aachen/D, 2Institute of Complex Systems,
Cellular Biophysics, ICS-4, Forschungszentrum Jülich GmbH, Jülich/D) |
03 |
Jana Gehlen1, S. Esser1, C. Haselier2, K. Schaffrath2, S. Johnen2, P. Walter2,
F. Müller1 (1Institute of Complex Systems, Cellular Biophysics, ICS-4,
Forschungszentrum Jülich, Jülich/D, 2Department of Ophthalmology,
RWTH Aachen University, Aachen/D) |
04 |
Archana Jalligampala1,2,3, C. Kelbsch1, K. Stingl2, T. Strasser2, T. Peters2,
E. Zrenner1,3, B. Wilhelm2, D.L. Rathbun1,3 (1Experimental Retinal Prosthetics Group
at Institute for Ophthalmic Research University of Tübingen, Tübingen/D,
2Pupil Research Group at the Centre for Ophthalmology, University Hospitals
Tübingen, Tübingen/D, 3Centre for Integrative Neuroscience at University
of Tübingen, Tübingen/D) |
05 |
Mahdi Sadeghi1,2, Z. Hosseinzadeh1,2, D.L. Rathbun1,2 (1University of Tübingen,
Tübingen/D, 2Eye hospital, Experimental Retinal Prosthetics Group, Tübingen/D) |
06 |
Wadood Haq, A. Speck, S. Basavaraju, J. Dieter, E. Zrenner
(University of Tübingen, Institute for Ophthalmic Research, Tübingen/D) |
07 |
Kim Schaffrath1, S. Diarra1, J. Gehlen2, F. Müller2, P. Walter1, S. Johnen1 (1Department
of Ophthalmology, University Hospital RWTH Aachen, Aachen/D, 2Institute of
Complex Systems, Cellular Biophysics, ICS-4, Forschungszentrum Jülich, Jülich/D) |
08 |
Christine Haselier1, S. Biswas2, S. Rösch3, G. Thumann4, F. Müller2, P. Walter1
(1Department of Ophthalmology RWTH Aachen University Aachen, Aachen/D,
2Institute of Complex Systems Cellular Biophysics ICS-4 Forschungszentrum Jülich,
Jülich/D, 3Clinical Department of Small Animals University of Leipzig, Leipzig/D,
4Département des neurosciences cliniques Service d’ophthalmologie Hôpitaux
universitaires de Genève, Geneva/CH) |
16:40 h |
Coffee break in the industrial exhibition |
17:10 h |
2nd Session Systems, Tools and TechnologyChair:A lfred Stett (Reutlingen/D) Gregg Suaning (Sydney/AUS) |
09 |
Kazim Hilmi Or (Private Office of Ophthalmology, Istanbul/TR) |
10 |
Mahmut Emin Celik, E. Aydin (Electrical Electronics Engineering Department,
Faculty of Engineering, Gazi University, Ankara/TR) |
11 |
Pascal Raffelberg1, A. Erbslöh1, R. Viga1, R. Kokozinski1,2 (University Duisburg
Essen, Electronic Components and Circuits, Duisburg/D, 2Fraunhofer Institute
of Microelectronic Circuits and Systems, Duisburg/D) |
12 |
Alfred Stett1, R. Daschner1, A. Rothermel2, R. Rudorf1, S. Rudorf1 (1Retina Implant
AG, Reutlingen/D, 2Institute of Microelectronics, University of Ulm, Ulm/D) |
13 |
Andreas Erbslöh1, P. Raffelberg1, R. Viga1, R. Kokozinski1,2, A. Grabmaier1,2
(1University Duisburg Essen, Electronic Components and Circuits, Duisburg/D,
2Fraunhofer Institute of Microelectronic Circuits and Systems, Duisburg/D) |
14 |
Marta Airaghi Leccardi1, L. Ferlauto1, N.A.L. Chenais1, M. Bevilacqua1,
T.J. Wolfensberger2, K. Sivula3, D. Ghezzi1 (1Medtronic Chair in Neuroengineering,
Center for Neuroprosthetics, Institute of Bioengineering, School of Engineering,
École Polytechnique Fédérale de Lausanne, Lausanne/CH, 2Hôpital Ophtalmique
Jules Gonin, Université de Lausanne, Lausanne/CH, 3Laboratory for Molecular
Engineering of Optoelectronic Nanomaterials, Institute of Chemical Sciences and
Engineering, School of Basic Science, École Polytechnique Fédérale de Lausanne,
Lausanne/CH) |
18:40 h |
End of the scientific program on Friday |
20:00 h |
Conference dinner |
Saturday, 2nd December, 2017
09:30 h |
3rd Session Data from preclinical experimentsChair:Takeshi Morimoto (Osaka/J) Tibor Karl Lohmann (Aachen/D) |
15 |
Gregg Suaning1, A. Barriga-Rivera2 (1University of Sydney, Sydney/AUS,
2University of Pable de Olavide, Division of Neuroscience, Sevilla/E) |
16 |
Takeshi Morimoto1, H. Kanda1, K. Hozumi2, K. Nishida2, T. Fujikado1
(1Department of Applied Visual Science, Osaka University Graduate School of
Medicine, Osaka/J, 2Department of Ophthalmology, Osaka University Graduate
School of Medicine, Osaka/J) |
17 |
Tibor Karl Lohmann, F. Haiss, C. Barz1,3, C. Werner, A.M. van der Meer,
K. Schaffrath, A.C. Schnitzler, G. Rößler, F. Waschkowski, W. Mokwa, P. Walter
(Department of Ophthalmology, University Hospital RWTH Aachen, Aachen/D,
Institute for Materials in Electrical Engineering I, RWTH Aachen University,
Aachen/D, Institute for Neuroscience and Medicine INM-2, Research Centre
Jülich/D) |
18 |
Seif Eldawlatly, E. Mounir, B. Abdullah, H.M.K. Mahdi
(Computer and Systems Engineering Department, Faculty of Engineering,
Ain Shams University, Cairo/EGY) |
19 |
Viviana Rincón Montes1, J. Gehlen2, S. Lück3, W. Mokwa3, F. Müller2, P. Walter4,
A. Offenhäusser1 (1Institute of Complex Systems, Bioelectronics, ICS-8, Forschungszentrum
Jülich/D, 2Institute of Complex Systems, Cellular Biophysics, ICS-4,
Forschungszentrum Jülich/D, 3Department of Materials in Electrical Engineering 1,
RWTH Aachen University, Aachen/D) |
20 |
Hiroyuki Kanda1, T. Miyoshi2, T. Morimoto1, T. Fujikado1 (1Dept. of Applied Visual
Science, Graduate School of Medicine, Osaka University, Suita/J, 2Dept. Of
Integrative Physiology, Graduate School of Medicine, Osaka University, Suita/J) |
21 |
Larissa Höfling1,2, F. Jetter1,2, P. Berens3,4,5, G. Zeck1 (Neurophysics Research
Group, Natural and Medical Sciences Institute, University of Tübingen, Tübingen/D,
2Graduate School of Neural Information Processing, University of Tübingen,
Tübingen/D, 3Institute of Ophthalmic Research, University of Tübingen, Tübingen/D,
4Centre for Integrative Neuroscience, University of Tübingen, Tübingen/D,
5Bernstein Center for Computational Neuroscience, University of Tübingen, Tübingen/D) |
22 |
Zohreh Hosseinzadeh, D. Rathbun (Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen/Germany.) |
11:30 h |
Coffee break in the industrial exhibition |
12:00 h |
4th Session Clinical Experiences:
Chair: |
23 |
Katarina Stingl1, R. Schippert2, K.U. Bartz-Schmidt1, D. Besch1, T.L. Edwards3,
F. Gekeler1,4, R.E. MacLaren3, J. Roider5, H. Sachs6, E. Zrenner1,7 (1Centre for
Ophthalmology, University of Tübingen, Tübingen/D, 2Retina Implant AG,
Reutlingen/D, 3Nuffield Laboratory of Ophthalmology, Oxford Eye Hospital, Oxford
University Hospitals NHS Foundation Trust, University of Oxford, Oxford/UK,
4Klinikum Stuttgart – Katharinenhospital, Eye Hospital, Stuttgart/D, 5Department of
Ophthalmology, University of Kiel, Kiel/Germany, 6Klinikum Dresden Friedrichstadt,
University Teaching Hospital, Eye Hospital, Dresden/D, 7Werner Reichardt Centre
for Integrative Neuroscience, University of Tübingen, Tübingen/D) |
24 |
Florian Gekeler1,2, K. Stingl2, R. MacLaren3, H. Sachs4, E. Zrenner2,
K.U. Bartz-Schmidt2 (1Department of Ophthalmology, Katharinenhospital,
Stuttgart/D, 2Center for Ophthalmology, University of Tübingen, Tübingen/D,
3Oxford University, Oxford/UK, 4Städtisches Klinikum Dresden, Dresden/D.) |
25 |
Takashi Fujikado1, T. Endo2, K. Hozumi2, H. Kanda1, T. Morimoto1, M. Hirota2,
M. Ozawa3 (1Applied Visual Science, Osaka University, Osaka/J, 2Ophthalmology,
Osaka University Graduate School of Medicine, Osaka/J, 3Nidek Co., Gamagori/J) |
26 |
Matthew Petoe1,2, D. Nayagam1,2,3, M. Shivdasani1,2, J. Villalobos1,2, O. Burns1,
P. Thien1,2, S. Epp1, C. McGowan1, R.A. Williams3,4, C.M. Salinas-LaRosa4, C. Abbott5,6,
A. Brandli5,6, J. Yeoh5,6, M. Korikkar1, S. Titchener1, P. Seligman1,2, W. Kentler7,
N. Barnes8,9, J. Walker8, R. Dengate8, A. Scott8, C. Luu5,6, L. Ayton5,6, C. Williams1,2,
R. Shepherd1,2, P. Allen5,6 (1Bionics Institute, East Melbourne/AUS, 2Medical Bionics
Department, University of Melbourne, Mebourne/AUS 3Department of Pathology,
University of Melbourne, Melbourne/AUS, 4Department of Anatomical Pathology,
St Vincent’s Hospital Melbourne,Melbourne/AUS, 5Centre for Eye Research
Australia, Royal Victorian Eye and Ear Hospital, Melbourne/AUS, 6Ophthalmology,
University of Melbourne, Department of Surgery, Melbourne/Australia, 7School
of Engineering, University of Melbourne/AUS, 8Data61, Canberra/AUS, 9Research
School of Engineering, Australian National University, Canberra/AUS) |
13:00 h |
Lunch break in the industrial exhibition |
14:00 h |
5th Session Clinical Experiences:
Chair: |
27 |
Emin Özmert, B. Baskak, R. Arslanta, Y. Kır, A. Kuşman, Z. Baran
(Ankara University Department of Ophthalmology and Brain Research Center,
Ankara University, Ankara/TR) |
28 |
Laura Cinelli, S. Rizzo (Azienda Ospedaliero-Universitaria Careggi SOD Oculistica,
Firenze/I) |
29 |
Arnaud Lesimple, M. Flourence, Argus II study group (Second Sight Medical
Products, Lausanne/CH) |
30 |
Nilufer Koyluoglu Unal1, F. Akkan2, E. Altındag3, R. Arslantas4, Y.Z. Arslan5
(1Medical School of Istinye University, Liv Hospital International, Istanbul/TR,
2Etiler Dunyagoz Hospital, Istanbul/TR, 3Medical School of Istanbul Bilim University,
Istanbul/TR, 4Baskent University, Ankara/TR, 5Department of Mechanical
Engineering, Istanbul University, Istanbul/TR) |
31 |
Dilek Güven, M. Demir, D. Özcan, S. Tiryaki Demir, H. Kacar, S. Cevher
(Sisli Hamidiye Etfal Training and Research Hospital Department of Ophthalmology,
Istanbul/TR) |
32 |
Kim Schaffrath, H. Schimitzek, P. Walter (Department of Ophthalmology,
University Hospital RWTH Aachen, Aachen/D) |
33 |
Eduardo Fernandez1,2, A. Alfaro2,3 (1Bioengineering Institute, Miguel Hernández
University of Elche, Elche/E, 2CIBER-BBN, Madrid/E, 3Department of Neurology,
Hospital Vega Baja, Orihuela/E) |
15:45 h |
Coffee break in the industrial exhibition |
16:00 h |
6th Session Improvements, Modifications and New IdeasChair:S helley I. Fried (Boston/USA) Gislin Dagnelie (Baltimore/USA) |
33a |
Jan v. Meurs1, Y. Le Mer2, M. Muqit3, S. Picaud4, D. Palanker5 (1Oogziekenhuis Rotterdam/NL, 2Fondation Ophtalmologique A. De Rothschild, Paris/F, 3Moorfields Eye Hospital NHS Foundation Trust, London/UK, 4Institut de la Vision, Paris/F, 5Stanford University, Standford/USA) |
34 |
Kenta Hozumi1, T. Endo2, M. Hirota3, H. Kanda3, T. Morimoto3, K. Nishida1,
T. Fujikado3 (1Department of Ophthalmology, Osaka University Graduate School
of Medicine, Osaka/J, 2Osaka Women’s and Children’s Hospital, Osaka/J,
3Department of Applied Visual Science, Osaka University Graduate School of
Medicine, Osaka/J) |
35 |
Gislin Dagnelie1, M. Barry1, A. Caspi2, A. Roy2, P. Gibson3, K. Kramer3 (1Johns
Hopkins University, Baltimore/USA, 2Second Sight Medical Products, Sylmar/USA,
3Minnesota Health Solutions & Advanced Medical Electronics Corp, Minneapolis/USA) |
36 |
Shelley I. Fried1,2, S.W. Lee2 (1Boston VA HealthCare System, Boston/USA,
2Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical
School, Boston/USA) |
37 |
Christine L. Zolli1,2 (1Rutgers University, New Jersey/USA,
2Wills Eye Hospital – Jefferson Medical School, Philadelphia/USA) |
38 |
Manuela Schiek1, O.S. Abdullaeva1, F. Balzer2, M. Schulz3, A. Luetzen3, J. Parisi1,
K. Dedek4 (1Institute of Physics, University of Oldenburg, Oldenburg/D,
2University of Southern Denmark, Denmark/DK, 3Kekule Insitute for Organic
Chemistry and Biochemistry, University of Bonn, Bonn/D, 4Institute for Biology and
Environmental Sciences, University of Oldenburg, Oldenburg/D) |
39 |
Sabine Diarra1, F. Waschkowski2, A. Garcia Moreno2, Z. Izsvák3, Z. Ivics4,
G. Thumann5, U. Schnakenberg2, F. Müller6, W. Mokwa2, P. Walter1, S. Johnen1
(1Department of Ophthalmology, University Hospital RWTH Aachen, Aachen/D,
2Institute for Materials in Electrical Engineering I, RWTH Aachen University,
Aachen/D, 3Max Delbrück Center for Molecular Medicine in the Helmholtz Society,
Berlin/D, 4Paul-Ehrlich-Institute, Langen/D, 5University of Geneva, University Hospitals
of Geneva, Department of Ophthalmology, Geneva/CH, 6Institute of Complex
Systems, Cellular Biophysics, ICS-4, Forschungszentrum Jülich GmbH, Jülich/D) |
40 |
Michael Oeverhaus, D. Dekowski, M. Stöhr, J. Holtemeyer,
B. Schaperdoth-Gerlings, J. Esser, A. Eckstein (Department of Ophthalmology,
University Hospital Essen, Essen/D) |
41 |
Peter Walter (Department of Ophthalmology, RWTH Aachen University,
Aachen/D) |
18:00 h |
Peter Walter (Department of Ophthalmology, RWTH Aachen University,
Aachen/D) |
18:15 h |
End of Artificial Vision 2017 |
AuthorsBack to top
|
Marta Airaghi Leccardi Laura Cinelli Dr. Gislin Dagnelie Dipl.-Biol. Sabine Diarra Dr. Ing. Damian Dudek Dr. Seif Eldawlatly Andreas Erbslöh Prof. Dr. Eduardo Fernandez Shelley Fried MD, PhD Prof. Takashi Fujikado Jana Gehlen Prof. Dr. Florian Gekeler Helma Gusseck Dr. Dilek Güven |
Dr. Wadood Haq Dr. rer. nat. Christine Haselier Larissa Höfling Zohreh Hosseinzadeh Kenta Hozumi Archana Jalligampala M.Sc. Hiroyuki Kanda Prof. Dr. Nilufer Koyluoglu Unal Arnaud Lesimple Tibor Karl Lohmann Takeshi Morimoto Prof. Dr. Frank Müller Michael H. Oeverhaus Dr. Kazim Hilmi Or |
Prof. Dr. Emin Özmert Dr. Matthew Petoe Pascal Raffelberg M.Sc. Dr. Daniel L. Rathbun Viviana Rincón Montes Mahdi Sadeghi Kim Schaffrath Dr. Manuela Schiek Dr. Alfred Stett Katarina Stingl Prof. Gregg J. Suaning Univ. Prof. Dr. Stefan Uhlig Anna-Marina Prof. Dr. Peter Walter Dr. Christine Zolli |
ExhibitorsBack to top
|
Alimera Sciences Ophthalmologie GmbH |
Bayer Vital GmbH |
|
D.O.R.C. Deutschland GmbH |
Geuder AG |
|
Heidelberg Engineering GmbH |
Pharm-Allergan GmbH |
|
Pixium Vision |
PRO RETINA Deutschland e. V. |
|
Retina Implant AG |
Santhera (Germany) GmbH |
|
Second Sight Medical Products (Switzerland) Sàrl |
Ursapharm Arzneimittel GmbH |
|
VANDA Pharmaceuticals Germany GmbH c/o Satellite Office |
ZEISS |
Your way to AachenBack to top
International Airports. High Speed Train System
From Frankfurt: Take the ICE High Speed train from Frankfurt Airport Station to Cologne Main Station (approx. 1h) and continue to Aachen Main Station (approx. 45 – 60 min).
From Düsseldorf: Take the train from Düsseldorf Airport Station to Düsseldorf Main Station (approx. 10 min) and than continue to Aachen Main Station (approx. 1.5 h).
From Cologne. Take the train from Cologne Airport Station to Cologne Main Station (approx. 15 min) and than continue to Aachen Main Station (approx. 45 – 60 min).
From Aachen Main Station take a taxi to Technologiezentrum at Europaplatz
By car
From Frankfurt Airport you can drive highway A3 to Cologne and then change to A4 direction to Aachen. At AK Aachen please change to A544 direction Aachen Europaplatz (approx. 3 h).
From Düsseldorf Airport. A52 Z A61 Z A44. Then A544 direction Europaplatz (approx. 95 km, 1 h)
From Cologne Airport. Take the A59, then change to A599 followed by A4 towards Aachen. Then A544 direction Europaplatz. (approx. 82 km, 1 h)
Meeting address
Technologiezentrum Europaplatz. Dennewartstraße 25-27. 52068 Aachen, Germany.